Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC-Reference-Cited by-同舟云学术

Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: Preclinical models to improve HIPEC

Published:2017-10 Issue:1 Volume:531 Page:143-152
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Roy P.,Canet-Jourdan C.,Annereau M.,Zajac O.,Gelli M.,Broutin S.,Mercier L.,Paci A.,Lemare F.,Ducreux M.,Elias D.,Malka D.,Boige V.,Goéré D.,Jaulin F.

Funder

Gustave Roussy fund raising on colorectal cancer (Roulons pour le colon/mars bleu)

ATIP-AVENIR program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines;Atallah;Int. J. Hyperthermia,2004

2. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study;Bloemendaal;Eur. J. Surg. Oncol.,2005

3. Selection of chemotherapy for hyperthermic intraperitoneal use in gastric cancer;Braam;Crit. Rev. Oncol. Hematol.,2015

4. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence: postoperative course and long-term outcome;Brouquet;Ann. Surg. Oncol.,2009

5. Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan;Canbay;Ann. Surg. Oncol.,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1/2 dose escalation and expansion trial;European Journal of Surgical Oncology;2024-09

2. Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers;Annals of Surgical Oncology;2024-01-04

3. Building consensus on the application of organoid-based drug sensitivity testing in cancer precision medicine and drug development;Theranostics;2024

4. Effects of Hyperthermia and Hyperthermic Intraperitoneal Chemoperfusion on the Peritoneal and Tumor Immune Contexture;Cancers;2023-08-29

5. Advances in the management of peritoneal malignancies;Nature Reviews Clinical Oncology;2022-09-07